Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been admitted to hospital with a stroke or a mini-stroke (sometimes called a TIA), which happened within the last 2 weeks.
- Brain scans (such as a CT scan or MRI) support the diagnosis of a stroke or mini-stroke.
- You have a smartphone and are able to use an app called "ECG247" for the study.
- You are expected to live for more than 6 months.
- You have a permanent address in Norway.
- You are able to give your own consent to take part, or someone is able to give consent on your behalf, and you are willing to follow the study requirements.
Who may not be able to join:
- You have already been diagnosed with an irregular heart rhythm called atrial fibrillation (AF) or atrial flutter before joining the trial.
- You are currently taking blood-thinning medications (such as apixaban, rivaroxaban, edoxaban, dabigatran, or warfarin), or there is a medical reason you cannot take them — except for short-term use to prevent blood clots.
- You have an implanted heart device, such as a pacemaker, a defibrillator (ICD), or a small heart monitor (loop recorder).
- Scans have shown a significant narrowing (more than 70%) in the main neck artery on the same side as your stroke.
- You are pregnant.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +4747621336
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Detection rate of atrial fibrillation; Time from enrollment to treatment initiation with anticoagulant medicine; Time from enrollment to detection of first AF episode; Total duration of heart rate monitoring; Numbers of participants with secondary stroke/TIA and/or major bleeding
Can't join this trial?
Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.